Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 21,751,284 | 21,751,284 | 0 | $956.40M | $1.10B | 32.08% | +$140.30M |
| Kymera Therapeutics, Inc.(KYMR) | 5,161,801 | 5,161,801 | 0 | $154.08M | $244.31M | 7.15% | +$90.23M |
| Revolution Medicines, Inc.(RVMD) | 5,981,212 | 3,478,612 | -2,502,600 | $232.13M | $157.76M | 4.61% | -$74.38M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 4,370,024 | 3,075,907 | -1,294,117 | $149.41M | $119.96M | 3.51% | -$29.45M |
| Tyra Biosciences, Inc.(TYRA) | 4,661,194 | 4,661,194 | 0 | $74.53M | $109.58M | 3.21% | +$35.05M |
| Olema Pharmaceuticals, Inc.(OLMA) | 9,135,893 | 9,135,893 | 0 | $98.85M | $109.08M | 3.19% | +$10.23M |
| Structure Therapeutics IncADS | 2,487,762 | 2,238,986 | -248,776 | $97.69M | $98.27M | 2.87% | +$574.7K |
| Cullinan Therapeutics, Inc.(CGEM) | 5,750,683 | 5,750,683 | 0 | $100.29M | $96.27M | 2.82% | -$4.03M |
| Xoma Royalty Corporation | 3,633,743 | 3,633,743 | 0 | $86.08M | $96.22M | 2.81% | +$10.14M |
| Axsome Therapeutics, Inc.(AXSM) | 955,000 | 1,046,000 | +91,000 | $76.88M | $94.00M | 2.75% | +$17.13M |
| Protagonist Therapeutics Inc | 3,319,290 | 1,850,167 | -1,469,123 | $115.01M | $83.26M | 2.44% | -$31.76M |
| 4d Molecular Therapeutics In | 3,922,413 | 7,382,642 | +3,460,229 | $82.33M | $79.81M | 2.33% | -$2.53M |
| AC Immune SASHS(ACIU) | 18,834,936 | 19,522,436 | +687,500 | $75.15M | $73.79M | 2.16% | -$1.36M |
| GH Research PLC(GHRS) | 10,400,158 | 10,400,158 | 0 | $121.27M | $69.58M | 2.04% | -$51.69M |
| Kura Oncology, Inc.(KURA) | 4,082,037 | 3,371,761 | -710,276 | $84.05M | $65.88M | 1.93% | -$18.16M |
| Third Harmonic Bio Inc | 4,365,933 | 4,365,933 | 0 | $56.76M | $59.16M | 1.73% | +$2.40M |
| Ionis Pharmaceuticals, Inc.(IONS) | 3,186,376 | 1,451,879 | -1,734,497 | $151.86M | $58.16M | 1.70% | -$93.70M |
| Zymeworks Inc.(ZYME) | 5,870,000 | 4,607,935 | -1,262,065 | $49.95M | $57.83M | 1.69% | +$7.88M |
| Essa Pharma Inc | 8,748,629 | 8,748,629 | 0 | $46.02M | $53.02M | 1.55% | +$7.00M |
| Agios Pharmaceuticals, Inc.(AGIO) | 1,190,107 | 1,190,107 | 0 | $51.32M | $52.88M | 1.55% | +$1.56M |
| Celcuity Inc.(CELC) | 3,466,000 | 3,466,000 | 0 | $56.77M | $51.68M | 1.51% | -$5.10M |
| 89bio Inc | 7,568,479 | 6,811,631 | -756,848 | $60.62M | $50.41M | 1.47% | -$10.22M |
| Foghorn Therapeutics Inc.(FHTX) | 5,302,000 | 5,302,000 | 0 | $30.49M | $49.36M | 1.44% | +$18.88M |
| Lakefront Biotherapeutics NVADR(LKFT) | 1,569,422 | 1,569,422 | 0 | $38.89M | $45.18M | 1.32% | +$6.29M |
| IDEAYA Biosciences, Inc.(IDYA) | 1,162,306 | 1,409,993 | +247,687 | $40.81M | $44.67M | 1.31% | +$3.86M |
| Annexon, Inc.(ANNX) | 7,000,000 | 7,000,000 | 0 | $34.30M | $41.44M | 1.21% | +$7.14M |
| CG Oncology, Inc.(CGON) | 2,417,885 | 994,596 | -1,423,289 | $76.33M | $37.53M | 1.10% | -$38.81M |
| Repare Therapeutics Inc | 10,333,600 | 10,333,600 | 0 | $34.10M | $35.55M | 1.04% | +$1.45M |
| Newamsterdam Pharma Company ORDINARY SHARES | 1,521,948 | 1,521,948 | 0 | $29.24M | $25.26M | 0.74% | -$3.97M |
| Xencor, Inc.(XNCR) | 0 | 850,000 | +850,000 | $0 | $17.09M | 0.50% | +$17.09M |
| Eledon Pharmaceuticals, Inc.(ELDN) | 6,293,282 | 6,293,282 | 0 | $16.61M | $15.67M | 0.46% | -$944.0K |
| TScan Therapeutics, Inc.(TCRX) | 2,989,474 | 2,989,474 | 0 | $17.49M | $14.89M | 0.44% | -$2.60M |
| Engene Holdings Inc COM | 2,251,037 | 2,251,037 | 0 | $21.23M | $14.86M | 0.43% | -$6.37M |
| Immunic, Inc.(IMUX) | 8,902,972 | 8,902,972 | 0 | $9.88M | $14.69M | 0.43% | +$4.81M |
| Allakos Inc | 16,552,417 | 16,552,417 | 0 | $16.55M | $10.81M | 0.32% | -$5.74M |
| Avalo Therapeutics, Inc.(AVTX) | 0 | 967,000 | +967,000 | $0 | $9.15M | 0.27% | +$9.15M |
| Ikena Oncology Inc | 4,769,164 | 4,769,164 | 0 | $7.87M | $8.25M | 0.24% | +$381.5K |
| Cidara Therapeutics Inc | 343,055 | 703,065 | +360,010 | $4.10M | $7.56M | 0.22% | +$3.46M |
| CytomX Therapeutics, Inc.(CTMX) | 5,228,461 | 5,228,461 | 0 | $6.38M | $6.17M | 0.18% | -$209.1K |
| Vigil Neuroscience Inc | 1,813,633 | 1,813,633 | 0 | $7.25M | $6.17M | 0.18% | -$1.09M |
| Vistagen Therapeutics, Inc.(VTGN) | 2,000,000 | 2,000,000 | 0 | $6.96M | $6.02M | 0.18% | -$940.0K |
| Verastem, Inc.(VSTM) | 1,685,219 | 1,685,219 | 0 | $5.02M | $5.04M | 0.15% | +$16.9K |
| Ovid Therapeutics Inc.(OVID) | 3,853,818 | 3,853,818 | 0 | $2.96M | $4.55M | 0.13% | +$1.58M |
| Pieris Pharmaceuticals Inc | 257,626 | 257,626 | 0 | $2.55M | $4.31M | 0.13% | +$1.77M |
| Verve Therapeutics Inc | 650,000 | 650,000 | 0 | $3.17M | $3.15M | 0.09% | -$26.0K |
| SAB Biotherapeutics, Inc.(SABS) | 917,826 | 917,826 | 0 | $2.85M | $2.48M | 0.07% | -$367.1K |
| Molecular Partners AGADS(MOLN) | 443,221 | 443,221 | 0 | $3.17M | $2.14M | 0.06% | -$1.03M |
| Elevation Oncology Inc | 2,312,200 | 2,966,836 | +654,636 | $6.24M | $1.78M | 0.05% | -$4.46M |
| Glycomimetics Inc | 9,544,262 | 9,544,262 | 0 | $2.69M | $1.61M | 0.05% | -$1.07M |
| Inventiva S.A.ADS(IVA) | 686,040 | 686,040 | 0 | $2.02M | $1.27M | 0.04% | -$754.6K |
| Tenax Therapeutics, Inc.(TENX) | 0 | 339,549 | +339,549 | $0 | $1.17M | 0.03% | +$1.17M |
| Engene Holdings IncW EXP 10 31 202 *W EXP 10/31/202 | 945,402 | 945,402 | 0 | $1.31M | $803.7K | 0.02% | -$510.4K |
| Molecular Templates Inc | 522,238 | 522,238 | 0 | $600.6K | $733.7K | 0.02% | +$133.2K |
| Nls Pharmaceutics Ltd | 0 | 143,676 | +143,676 | $0 | $728.4K | 0.02% | +$728.4K |
| Forte Biosciences Inc | 0 | 119,282 | +119,282 | $0 | $668.0K | 0.02% | +$668.0K |
| Aslan Pharmaceuticals LtdADS | 1,049,999 | 0 | -1,049,999 | $315.0K | $0 | — | -$315.0K |
| Calliditas Therapeutics AbADS | 750,000 | 0 | -750,000 | $29.24M | $0 | — | -$29.24M |
| Forte Biosciences Inc | 2,982,105 | 0 | -2,982,105 | $1.60M | $0 | — | -$1.60M |
| Janux Therapeutics, Inc.(JANX) | 441,528 | 0 | -441,528 | $18.50M | $0 | — | -$18.50M |
| Merus N V | 1,279,049 | 0 | -1,279,049 | $75.68M | $0 | — | -$75.68M |
| Nls Pharmaceutics LtdSHS | 5,747,126 | 0 | -5,747,126 | $1.25M | $0 | — | -$1.25M |
| Rezolute, Inc.(RZLT) | 190,815 | 0 | -190,815 | $820.5K | $0 | — | -$820.5K |
| Roivant Sciences Ltd.SHS(ROIV) | 2,742,409 | 0 | -2,742,409 | $28.99M | $0 | — | -$28.99M |
| Unicycive Therapeutics Inc | 2,200,000 | 0 | -2,200,000 | $1.10M | $0 | — | -$1.10M |
| Viracta Therapeutics Inc | 3,614,662 | 0 | -3,614,662 | $1.97M | $0 | — | -$1.97M |